SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-021942
Filing Date
2023-06-21
Accepted
2023-06-21 12:55:02
Documents
15
Period of Report
2023-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 70627
2 ex99-4.htm EX-99.4 133723
3 ex99-5.htm EX-99.5 117365
4 ex99-6.htm EX-99.6 92224
  Complete submission text file 0001493152-23-021942.txt   636285

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE invo-20230316.xsd EX-101.SCH 3033
6 XBRL LABEL FILE invo-20230316_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE invo-20230316_pre.xml EX-101.PRE 22371
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 3309
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39701 | Film No.: 231028920
SIC: 3841 Surgical & Medical Instruments & Apparatus